Semaglutide 2.4 mg Once-Weekly Investigated for Effect and Safety in Overweight and Obese Adults
STEP 1: Research Study Investigating How Well Semaglutide Works in People Suffering From Overweight or Obesity
Abstract
A Phase 3 randomized trial evaluated the effect and safety of semaglutide 2.4 mg once-weekly for 68 weeks in 1961 adults with overweight or obesity.